GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ChromaDex Corp (FRA:OCD1) » Definitions » Cash Receipts from Fees and Commissions

ChromaDex (FRA:OCD1) Cash Receipts from Fees and Commissions


View and export this data going back to 2016. Start your Free Trial

What is ChromaDex Cash Receipts from Fees and Commissions?

Cash Receipts from Fees and Commissions only applicable to companies reporting Cash Flow from Operations in direct method.


ChromaDex (FRA:OCD1) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ChromaDex Corp (FRA:OCD1) » Definitions » Cash Receipts from Fees and Commissions
Traded in Other Exchanges
Address
10900 Wilshire Boulevard, Suite 600, Los Angeles, CA, USA, 90024
ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segment namely Consumer Products, Ingredients segment and Analytical Reference Standards and Services. Majority of the revenue is earned from Consumer Products segment.